These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23340539)

  • 1. A prospective evaluation of psychotherapeutic and illicit drug use in patients presenting with chronic pain at the time of initial evaluation.
    Manchikanti L; Cash KA; Malla Y; Pampati V; Fellows B
    Pain Physician; 2013 Jan; 16(1):E1-E13. PubMed ID: 23340539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables.
    Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD
    Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid epidemic in the United States.
    Manchikanti L; Helm S; Fellows B; Janata JW; Pampati V; Grider JS; Boswell MV
    Pain Physician; 2012 Jul; 15(3 Suppl):ES9-38. PubMed ID: 22786464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with opioid treatment guidelines for chronic non-cancer pain (CNCP) in primary care at a Veterans Affairs Medical Center (VAMC).
    Sekhon R; Aminjavahery N; Davis CN; Roswarski MJ; Robinette C
    Pain Med; 2013 Oct; 14(10):1548-56. PubMed ID: 23746149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
    Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: a prospective, observational study.
    Manchikanti L; Damron KS; McManus CD; Barnhill RC
    Pain Physician; 2004 Oct; 7(4):431-7. PubMed ID: 16858484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
    Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
    J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of illicit drug use among individuals with chronic pain in the Commonwealth of Kentucky: an evaluation of patterns and trends.
    Manchikanti L; Fellows B; Damron KS; Pampati V; McManus CD
    J Ky Med Assoc; 2005 Feb; 103(2):55-62. PubMed ID: 15751456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
    Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
    Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the prescription of opioids for chronic nonmalignant pain by Australian general practitioners.
    Holliday S; Magin P; Dunbabin J; Oldmeadow C; Henry JM; Lintzeris N; Attia J; Goode S; Dunlop A
    Pain Med; 2013 Jan; 14(1):62-74. PubMed ID: 23279722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
    Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
    Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does adherence monitoring reduce controlled substance abuse in chronic pain patients?
    Manchikanti L; Manchukonda R; Damron KS; Brandon D; McManus CD; Cash K
    Pain Physician; 2006 Jan; 9(1):57-60. PubMed ID: 16700282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study.
    Ives TJ; Chelminski PR; Hammett-Stabler CA; Malone RM; Perhac JS; Potisek NM; Shilliday BB; DeWalt DA; Pignone MP
    BMC Health Serv Res; 2006 Apr; 6():46. PubMed ID: 16595013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.
    Manchikanti L; Singh A
    Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.